including RNA degradation. Created with BioRender.com. Current antisense therapies typically consist of short nucleic acid molecules less than 30 nucleotides in length and can be produced through ...

RNA therapies use RNA molecules to modify gene expression through the use of RNA interference and antisense technologies. RNA therapies are used to treat infectious infections, cancer, and genetic ...

Development of this therapeutics is based on promising technologies such as RNA interference technology (RNAi), antisense technology. Moreover, Cancer diagnosis and treatment is currently undergoing a ...

After hours: February 19 at 4:35:20 PM EST Loading Chart for RNA ...

and promoter-associated long RNA. They have also been classified according to the position of the lncRNA in the genome relative to the target protein-coding gene as 1) antisense lncRNA, which is ...

We read every piece of feedback, and take your input very seriously.

Here, we employ a human mesencephalic neuronal cell differentiation model, LUHMES, with sensitive and high-resolution methods to discover enhancers (NET-CAGE), perform DNA conformation analysis ...

RNA polymerase binds to a region just before the gene, called the promoter, before moving down the DNA to the gene. Enhancers are regions of DNA that act as molecular switches for turning genes on or ...

Atherosclerotic cardiovascular disease is a major health concern worldwide and requires effective preventive measures. Lp(a) (lipoprotein [a]) has recently garnered attention as an independent risk ...